Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?

Схожие документы

• ‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
  по: Honore, Patrick M, et al.
  Опубликовано: (2015)
• Higher colistin dose during continuous renal replacement therapy: look before leaping!
  по: Honore, Patrick M., et al.
  Опубликовано: (2015)
• Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
  по: Honore, Patrick M., et al.
  Опубликовано: (2015)
• Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
  по: Honore, Patrick M., et al.
  Опубликовано: (2015)
• Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
  по: Honore, Patrick M., et al.
  Опубликовано: (2015)